publication venue for
- Optimizing the use of vilobelimab for the treatment of COVID-19. 2023
- Interferon lambda as a potential treatment for COVID-19.. 23. 2023
- Original antigen sin and COVID-19: implications for seasonal vaccination.. 22. 2022
- Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques.. 22. 2022
- Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system.. 20. 2020
- Alemtuzumab in allogeneic hematopoetic stem cell transplantation.. 11. 2011
- Treating human cancers with heat shock protein-peptide complexes: the road ahead.. 9. 2009
- Therapeutic antibodies to intracellular targets in cancer therapy.. 13. 2013
- Feverfew: weeding out the root of leukaemia.. 5. 2005
- HIV-1 cure strategies: why CRISPR? 2021
- Immunotherapy for castration-resistant prostate cancer: has its time arrived? 2020
- Ramucirumab for the treatment of gastric or gastro-esophageal junction cancer. 2019
- Antibody therapeutics for treating prostate cancer: where are we now and what comes next? 2016
- Opportunities and challenges for TCR mimic antibodies in cancer therapy. 2016
- Metreleptin and generalized lipodystrophy and evolving therapeutic perspectives. 2015
- Bevacizumab for the treatment of high-grade glioma: an update after phase III trials. 2014
- Bevacizumab for the treatment of high-grade glioma. 2012
- Abagovomab for ovarian cancer. 2011
- The role of talactoferrin alpha in the treatment of non-small cell lung cancer. 2010
- Monoclonal antibody therapies for solid tumors. 2009
- The role of cathelicidin and defensins in pulmonary inflammatory diseases. 2007
- Novel biologic therapies for psoriasis. 2004
- The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applications. 2004
- Drug discovery for inflammatory diseases. 2003
- Anticytokine therapy for osteoarthritis. 2001